Latest news about Kronox Lab Sciences
Kronox Lab Sciences
205.36
-9.82(-4.56%)
Company Performance:
View Company Insights1D-4.56%
1M+34.94%
6M+72.12%
1Y+21.84%
5Y+28.90%
More news about Kronox Lab Sciences
09Apr 26
KRONOX Lab Sciences Limited Issues Clarification on Share Price Movement Under Regulation 30
KRONOX Lab Sciences Limited filed a regulatory clarification on April 08, 2026, stating it is unaware of specific reasons for significant share price movement and attributing it to market factors. The company reaffirmed its commitment to timely disclosure of material information under SEBI Regulation 30, with Company Secretary Nikhil Goswami emphasizing continued adherence to listing regulations and applicable laws.
03Apr 26
Kronox Lab Sciences Submits SEBI Compliance Certificate for Q4FY26
Kronox Lab Sciences Limited has submitted its Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Q4FY26 to NSE and BSE. The certificate, issued by KFin Technologies Limited on April 1, 2026, confirms that details of securities dematerialized/rematerialized during the quarter ended March 31, 2026, have been properly reported to all relevant stock exchanges. The submission was made on April 3, 2026, by Company Secretary Nikhil Goswami, fulfilling the company's quarterly compliance obligations.
16Feb 26
KRONOX Lab Sciences Limited Publishes Unaudited Financial Results for Q3 FY26
KRONOX Lab Sciences Limited has published its unaudited financial results for the quarter and nine months ended December 31, 2025, following Board approval on February 14, 2026. The company fulfilled SEBI regulatory requirements by publishing results in Indian Express and Financial Express newspapers on February 16, 2026. The complete financial results are accessible through the company's website and stock exchange platforms.
14Feb 26
KRONOX Lab Sciences Reports Q3FY26 Results with Revenue of ₹2,527.40 Lakhs
KRONOX Lab Sciences Limited announced its Q3FY26 financial results showing revenue from operations of ₹2,527.40 lakhs and profit after tax of ₹658.90 lakhs for the quarter ended December 31, 2025. The nine months performance demonstrated revenue of ₹7,509.37 lakhs with profit after tax of ₹1,965.79 lakhs, reflecting steady growth in the company's specialty fine chemicals manufacturing business.
12Nov 25
Kronox Lab Sciences Reports Strong Financial Performance with Revenue of Rs 4,981.97 Lakhs for Half-Year
Kronox Lab Sciences, a manufacturer of high-purity specialty fine chemicals, announced robust financial results for Q2 and H1 FY2026. The company's Q2 revenue from operations reached ₹2,553.32 lakhs, with a profit after tax of ₹1,129.96 lakhs. For H1, revenue stood at ₹4,981.97 lakhs, with profit after tax at ₹2,546.70 lakhs. The Board approved the standalone unaudited financial results, which were reviewed by statutory auditors and recommended by the audit committee. Kronox Lab Sciences operates in a single reportable segment and had recently completed its IPO through a 100% Offer for Sale.
10Nov 25
Kronox Lab Sciences Secures Crucial Approval for Unit-IV Construction in Dahej
Kronox Lab Sciences Limited has received regulatory approval from the Gujarat Pollution Control Board (GPCB) for the construction of its Unit-IV building project in Dahej. This 'Consent to Establish' follows previously obtained environmental clearance and other statutory approvals. The company is now set to commence construction work for Unit-IV, marking a significant step in its expansion plans.
23Sept 25
Kronox Lab Sciences Secures Environmental Clearance for Unit-IV Project in Dahej
Kronox Lab Sciences Limited has received environmental clearance from the Central Government for the construction of its Unit-IV at Dahej. This approval completes all statutory requirements for the project, allowing the company to proceed with construction. The environmental clearance was the final pending approval, as mentioned during the company's Annual General Meeting on August 18, 2025. Nikhil Goswami, Company Secretary, announced the approval to stock exchanges, marking a significant milestone in the company's expansion plans.
13Aug 25
KRONOX Lab Sciences Reports Q1 FY26 Results: Sequential Growth Amid Year-on-Year Challenges
Kronox Lab Sciences Limited released Q1 FY26 results, showing sequential improvement but year-on-year decline. Total income rose 2.30% QoQ to ₹370.06 crore, while net profit surged 94.70% QoQ to ₹4.75 crore. However, YoY comparisons show a 5.20% drop in income and 65.10% decrease in net profit. EPS stood at ₹1.52, nearly doubling QoQ but down 65.10% YoY. The company's paid-up equity share capital remained stable at ₹15.62 crore.
11Aug 25
Kronox Lab Sciences Reports Flat Net Profit, Revenue Dips in Q1
Kronox Lab Sciences, a manufacturer of high purity specialty fine chemicals, reported Q1 financial results with a net profit of ₹62.79 crore, unchanged from the previous year. Revenue from operations decreased by 3.60% to ₹242.87 crore. Other income doubled to ₹8.73 crore. Total expenses reduced by 3.45%, helping to maintain profitability. EPS slightly improved to ₹1.70 from ₹1.67.
25Jul 25
KRONOX Lab Sciences Reappoints Key Directors and Announces AGM Book Closure Dates
Kronox Lab Sciences has scheduled its 16th AGM for August 18, 2025, with book closure dates set from August 9 to August 18, 2025. The Board has approved the reappointment of three key executives: Mr. Ketan Ramani as Managing Director, Mr. Jogindersingh Jaswal as Whole Time Director, and Mr. Pritesh Ramani as Whole Time Director, each for three-year terms starting September 1, 2025, subject to shareholder approval. The company has also appointed new Secretarial, Internal, and Cost Auditors.
22May 25
Kronox Lab Sciences Q4 Results: Net Profit Up, EBITDA Margin Declines
Kronox Lab Sciences announced Q4 financial results with revenue increasing 17.57% YoY to ₹261.00 crore. Net profit rose 6.78% YoY to ₹63.00 crore. However, EBITDA declined 2.53% to ₹77.00 crore, and EBITDA margin contracted significantly from 35.44% to 29.62%. The results indicate strong top-line growth but challenges in maintaining operational efficiency.
Industry Peers
Pidilite Industries
SRF
Gujarat Fluorochemicals
Navin Fluorine International
Himadri Speciality Chemical
Deepak Nitrite
Aether Industries
Aarti Industries
Atul
BASF
1,660.00
(+0.67%)
2,580.80
(+0.35%)
4,622.60
(+0.02%)
8,187.00
(-0.24%)
662.20
(+1.19%)
1,730.30
(-0.96%)
1,667.80
(+2.53%)
543.15
(+3.03%)
6,425.00
(-1.30%)
3,878.60
(-0.62%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
